(9-395) Administration of Midodrine, Droxidopa, or the Combination of Droxidopa and Midodrine for Discontinuing Hemodynamic-Stabilizing Pharmacotherapy: a Comparison of Oral Vasopressors in Critically Ill Patients
Wednesday, December 10, 2025
8:30 AM - 9:30 AM
Location: Bayside A, Level 1
Residency Program: Health First Holmes Regional Medical Center Residency Program Type: PGY2 (Critical Care Pharmacy) Residency Program Location: Florida
Co-Author(s): James Breslin, Joshua McBride, Brittany Pollio
